Using both imaging and biomarker tests for Alzheimer’s disease leads to more accurate diagnostic results, a Duke Medicine study suggests in this week’s Radiology.
In the press release, study author Jeffrey Petrella, M.D., explains, “This study marks the first time these diagnostic tests have been used together to help predict the progression of Alzheimer's. If you use all three biomarkers, you get a benefit above that of the pencil-and-paper neuropsychological tests used by doctors today… Each of these tests adds new information by looking at Alzheimer's from a different angle.”
This research was partially funded by the Dana Foundation.
-Ann L. Whitman